title: New clinical syndromes in dermatology.
abstract: Dermatologists are in the unique position to be able to diagnose serious systemic diseases through skin findings; in addition, cutaneous manifestations can be associated with internal symptoms and clarify the pathogenesis and treatment of challenging new syndromes. Calciphylaxix, now renamed Calcific Uremic Arteriolopathy, primarily affects patients with end-stage renal disease with concomitant hyperphosphatemia, increased calcium-phosphate product and hyperparathyroidism, skin biopsy and wound care are crucial parts of the diagnosis and treatment. Hyperhomocysteinemia may play a very important role in many cutaneous and systemic diseases including, chronic cutaneous wounds, systemic lupus erythematosus, Behcet's disease and psoriasis. Through a skin biopsy and biochemical analysis of the proteoglycans accumulation it may be possible to diagnose a new systemic mucinosis and prevent sudden death in patients with severe mitral valve prolapse. Nephrogenic Fibrosing Dermopathy is a newly described fibrosing disorder occurring in patients with end stage renal disease, the etiology and pathogenesis are still unknown, and the ultimate course of this disease has not been defined.
authors.affiliation: Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL 33136, USA. promanelli@med.miami.edu
authors.forename: Paolo
authors.initials: P
authors.lastname: Romanelli
authors.forename: Navid
authors.initials: N
authors.lastname: Bouzari
mesh_terms: D005355:Fibrosis; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications; D007676:Kidney Failure, Chronic / Q000150:complications; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000209:etiology; D013577:Syndrome